Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP

Molecular and Cellular Biology

Volumn 22, Issue 9, 2002, Pages 2984-2992

  Sang, Nianli ^a   Fang, Jie ^a   Srinivas, Vickram ^a   Leshchinsky, Irene ^a   Caro, Jaime ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIOXAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ONCOPROTEIN; PROTEIN DERIVATIVE; PROTEIN P300; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROXYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; TRANSACTIVATION;

ADENOVIRUS E1A PROTEINS; ANOXIA; ASPARTATE CARBAMOYLTRANSFERASE; BLOTTING, WESTERN; CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING); CELL LINE; DEFEROXAMINE; DIHYDROOROTASE; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; HYDROXYLATION; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIGASES; MIXED FUNCTION OXYGENASES; MULTIENZYME COMPLEXES; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN ISOFORMS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0036232662     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.9.2984-2992.2002     Document Type: Article

References (53)

1. An essential role for p300/ CBP in the cellular response to hypoxia
2. Recruitment of p300/CBP in p53-dependent signal pathways
3. Enhancer element at the 3′ flanking region controls transcriptional response to hypoxia in the human erythropoietin gene
4. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1
5. A conserved family of prolyl-4-hydroxylases that modify HIF
6. Role of HIF1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
7. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α
8. Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): Heterodimerization with ARNT is not necessary for nuclear accumulation of HIF1α
9. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
10. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein
11. Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300
12. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
13. Molecular mechanism of hypoxia-inducible factor 1-p300 interaction. A leucine-rich interface regulated by a single cysteine
14. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit
15. 2-dependent degradation domain via the ubiquitin-proteasome pathway
16. Negative regulation of hypoxia-inducible genes by the von Hippel Lindau protein
17. 2 sensing
18. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex
19. 2-regulated prolyl hydroxylation
20. Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha
21. Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α
22. Regulation of the hypoxia inducible transcription factor 1α by the ubiquitinproteasome pathway
23. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
24. The von Hippel-Lindau tumor suppressor gene
25. Suppression of tumor growth through disruption of hypoxia-inducible transcription
26. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) la and the HIF like factor
27. Identification of the von Hippel-Lindau disease tumor suppressor gene
28. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity
29. Independent function of two destruction domains in hypoxia-inducible factot-α chains activated by prolyl hydroxylation
30. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
31. Ubiquitination of HIF requires direct binding to the von Hippel-Lindau protein beta domain
32. Oxygen-regulated and transactivating domains in endothelial PAS protein 1: Comparison with hypoxia-inducible factor-lalpha
33. Activation of hypoxia-inducible factor-1, definition of regulatory domains within the a subunit
34. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription
35. Nonhypoxic pathway mediates the induction of hypoxia inducible factor 1 alpha (HIF-1α) in vascular smooth muscle cells
36. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth
37. HIF-1α is required for solid tumor formation and embryonic vascularization
38. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions
39. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity
40. Extreme N-terminus of E1A oncoprotein specifically associates with a new set of cellular proteins
41. Adenoviral E1A: Everlasting tool, versatile applications, continuous contributions and new hypotheses
42. Transforming region of 243R E1A contains two overlapping but distinct transactivation domains
43. Expression of hypoxia-inducible factor 1: Mechanisms and consequences
44. Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway
45. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor α (HIF-α) proteins
46. Structure of the VHL-ElonginC-ElonginB complex: Implications for VHL tumor suppressor function
47. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein
48. Interleukin-1 induces hypoxia inducible factor-1 in human gingival and synovial fibroblasts
49. Purification and characterization of hypoxia-inducible factor 1
50. Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: Implications for oxygen sensing
51. HIF-1 binding to VHL is regulated by stimulus-sensitive proline hydroxylation
52. Human p300 protein is a coactivator for the transcription factor MyoD
53. Modulation of hypoxiainducible factor la expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics